Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - imipramine hydrochloride, quantity: 10 mg - tablet, sugar coated - excipient ingredients: macrogol 8000; povidone; stearic acid; hypromellose; purified talc; glycerol; magnesium stearate; titanium dioxide; maize starch; microcrystalline cellulose; iron oxide red; colloidal anhydrous silica; lactose monohydrate; sucrose; copovidone - major depression. nocturnal enuresis (from the age of 5 years onwards and provided the possibility of organic causes has first been excluded).

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmaco australia ltd - clomipramine hydrochloride, quantity: 25 mg - tablet, sugar coated - excipient ingredients: lactose monohydrate; maize starch; microcrystalline cellulose; povidone; purified talc; glycerol; titanium dioxide; hypromellose; magnesium stearate; stearic acid; colloidal anhydrous silica; sucrose; macrogol 8000; iron oxide yellow; copovidone - major depression. obsessive-compulsive disorders and phobias in adults. cataplexy associated with narcolepsy

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - modafinil, quantity: 100 mg - tablet, uncoated - excipient ingredients: povidone; aluminium magnesium silicate; lactose monohydrate; purified talc; maize starch; croscarmellose sodium; magnesium stearate - modafinil is indicated:,? to improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy;,? to treat excessive sleepiness associated with moderate to severe chronic shift work sleep disorder where nonpharmacological interventions are unsuccessful or inappropriate;,? as an adjunct to continuous positive airways pressure (cpap) in obstructive sleep apnoea/hypopnoea syndrome in order to improve wakefulness.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - modafinil, quantity: 100 mg - tablet, uncoated - excipient ingredients: aluminium magnesium silicate; lactose monohydrate; croscarmellose sodium; povidone; maize starch; magnesium stearate; purified talc - modafinil is indicated:,? to improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy;,? to treat excessive sleepiness associated with moderate to severe chronic shift work sleep disorder where nonpharmacological interventions are unsuccessful or inappropriate;,? as an adjunct to continuous positive airways pressure (cpap) in obstructive sleep apnoea/hypopnoea syndrome in order to improve wakefulness.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - clomipramine hydrochloride, quantity: 25 mg - tablet, film coated - excipient ingredients: purified talc; maize starch; lactose monohydrate; sodium starch glycollate; magnesium stearate; povidone; titanium dioxide; hypromellose; macrogol 400 - for the treatment o f major depression; obsessive-compulsive disorders and phobias in adults; and cataplexy associated with narcolepsy.

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - imipramine hydrochloride, quantity: 25 mg - tablet, sugar coated - excipient ingredients: titanium dioxide; microcrystalline cellulose; colloidal anhydrous silica; sucrose; magnesium stearate; stearic acid; lactose monohydrate; hypromellose; maize starch; glycerol; povidone; iron oxide red; macrogol 8000; carnauba wax; purified talc; copovidone - major depression. nocturnal enuresis (from the age of 5 years onwards and provided the possibility of organic causes has first been excluded).

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - modafinil, quantity: 100 mg - tablet, uncoated - excipient ingredients: purified talc; aluminium magnesium silicate; lactose monohydrate; povidone; croscarmellose sodium; maize starch; magnesium stearate - modafinil is indicated: ? to improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy; ? to treat excessive sleepiness associated with moderate to severe chronic shift work sleep disorder where nonpharmacological interventions are unsuccessful or inappropriate; ? as an adjunct to continuous positive airways pressure (cpap) in obstructive sleep apnoea/hypopnoea syndrome in order to improve wakefulness.

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - methylphenidate hcl - capsule - 20 mg - methylphenidate hcl 20 mg

Israel - English - Ministry of Health

novartis israel ltd - methylphenidate hydrochloride - modified release capsules - methylphenidate hydrochloride 10 mg - methylphenidate - attention deficit hyperactivity disorder (adhd) .

Israel - English - Ministry of Health

novartis israel ltd - methylphenidate hydrochloride - modified release capsules - methylphenidate hydrochloride 20 mg - methylphenidate - attention deficit hyperactivity disorder (adhd).